Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

The Baupost Group

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$222M
Portfolio companies 24
Rounds per year 0.74
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.23
Exits 12
Key employees 7

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
  • Therapeutics
Summary

In 1982 was created The Baupost Group, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the Boston.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the The Baupost Group, startups are often financed by Omega Funds, SR One, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are Omega Funds, Fidelity Management and Research Company, SR One. In the next rounds fund is usually obtained by Omega Funds, Fidelity Management and Research Company, Silicon Valley Bank.

The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this The Baupost Group performs on 28 percentage points more the average number of lead investments. The top activity for fund was in 2014. The real fund results show that this VC is 23 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2019. The average startup value when the investment from The Baupost Group is more than 1 billion dollars.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Intarcia Therapeutics, Idenix Pharmaceuticals, Gossamer Bio. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Personal Health, Biotechnology.

We also calculated 7 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of The Baupost Group:
Typical Co-investors
The Baupost Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after The Baupost Group:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beril AG -
Books on Demand Canfield, Ohio, United States
Central Piedmont Investment Group -
GRE Capital -
Hejun Capital Beijing, Beijing, China
Jingu Zichan China, Guangdong, Shenzhen
Jingxin Venture Capital -
Lakson Investments Venture Capital Karachi, Pakistan, Sindh
Lendingkart Ahmedabad, Gujarat, India
Pivotal Capital California, Menlo Park, United States
Sallfort Privatbank AG Basel, Basel-Stadt, Switzerland
Scion Capital -
Senvest Management New York, New York, United States
Shore Ventures II -
Stakeboat Capital Bengaluru, India, Karnataka
TMCT Ventures California, Santa Monica, United States
W2 Labs England, London, United Kingdom
Wolfswood Partners New York, New York, United States
Z80 Labs Technology Incubator Buffalo, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cellarity

Biotechnology
Life Science
Pharmaceutical
$123M25 Feb 2021 Cambridge, Massachusetts, United States

Cullinan Oncology

Biopharma
Biotechnology
Medical Device
$131M17 Dec 2020 Cambridge, Massachusetts, United States

BOPU

Financial Services
Hedge Funds
Internet
Software
$20M01 Sep 2020 Boston, Massachusetts, United States

Nuvation Bio

Biotechnology
Pharmaceutical
$275M28 Oct 2019 New York, New York, United States

帆船

$3M03 Sep 2019 -

Wren Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
$24M22 Jan 2019 Cambridge, England, United Kingdom

Gossamer Bio

Biotechnology
Health Care
Therapeutics
$230M23 Jul 2018 San Diego, California, United States

Translate Bio

Biotechnology
Genetics
Medical
Therapeutics
$42M01 Dec 2017 Cambridge, Massachusetts, United States

Translate Bio

Biotechnology
Genetics
Medical
Therapeutics
$51M10 Jan 2017 Cambridge, Massachusetts, United States
News
Outbrain raises $200 million ahead of its IPO

– Outbrain, an adtech company, raised $200m funding.
– The round was led by Baupost Group.
– Outbrain filed for an IPO last week.

Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform

– Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform
– Ro is the healthcare technology company
– The company has completed a $500 million Series D fundraising round led by existing investors General Catalyst, FirstMark Capital and TQ Ventures, with significant participation from existing investors SignalFire, Torch Capital and BoxGroup as well as new investors Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776.
– The Series D brings Ro’s total fundraising since its founding in 2017 to $876 million.
– Ro will use the newly-raised capital to strengthen its vertically integrated primary care platform.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent The Baupost Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 31
Average round size 222M
Rounds per year 0.74
Peak activity year 2021
Lead investments 7
Follow on index 0.23
Exits 12
Group Appearance index 0.77

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cellarity

Biotechnology
Life Science
Pharmaceutical
$123M25 Feb 2021 Cambridge, Massachusetts, United States

Cullinan Oncology

Biopharma
Biotechnology
Medical Device
$131M17 Dec 2020 Cambridge, Massachusetts, United States

BOPU

Financial Services
Hedge Funds
Internet
Software
$20M01 Sep 2020 Boston, Massachusetts, United States

Nuvation Bio

Biotechnology
Pharmaceutical
$275M28 Oct 2019 New York, New York, United States

帆船

$3M03 Sep 2019 -

Wren Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
$24M22 Jan 2019 Cambridge, England, United Kingdom

Gossamer Bio

Biotechnology
Health Care
Therapeutics
$230M23 Jul 2018 San Diego, California, United States

Translate Bio

Biotechnology
Genetics
Medical
Therapeutics
$42M01 Dec 2017 Cambridge, Massachusetts, United States

Translate Bio

Biotechnology
Genetics
Medical
Therapeutics
$51M10 Jan 2017 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: